Standard on vaginal discharge of the Dutch College of General Practitioners (First revision);NHG-Standaard Fluor vaginalis: Eerste herziening

Huisarts en Wetenschap

Volumn 48, Issue 9, 2005, Pages 459-466

  Dekker, I H ^a   Boeke, A J P ^a   Gercama, A J ^a   Kardolus, G J ^a   Boukes, F S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC PROCEDURE; GENERAL PRACTITIONER; GYNECOLOGY; HUMAN; PATHOGENESIS; PRACTICE GUIDELINE; REVIEW; STANDARD; VAGINA DISCHARGE;

EID: 24144443488     PISSN: 00187070     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Alanen A. Does screening reduce preterm births? BMJ 2004;329:374.
2. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22.
3. Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA 2004;291:1368-79.
4. Andres FJ, Parker R, Hosein I, Benrubi GI. Clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis: a prospective double-blind clinical trial. South Med J 1992;85:1077-80.
5. Anonymus. Geneesmiddelen, zwangerschap en borstvoeding. 2e dr. Houten/Bilthoven: Stichting Health Base/RIVM, 2003.
6. Bergeron S, Binik YM, Khalife S, Pagidas K. Vulvar vestibulitis syndrome: a critical review. Clin J Pain 1997;13:27-42.
7. Bergeron S, Binik YM, Khalife S, Pagidas K, Glazer HI, Meana M, et al. A randomized comparison of group cognitive - behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain 2001;91:297-306.
8. Boeke AJP, Faas A. Interdokter-betrouwbaarheid bij de diagnostiek van vaginitis. Huisarts Wet 1985;28:395-7.
9. Boeke AJP, Dekker JH, Van Eijk JTM. Chlamydia trachomatis bij vrouwen met vaginale Wachten in de huisartspraktijk: hoe vaak komt het voor en bij wie moet je er aan denken. Huisarts Wet 1991;34:260-6.
10. Boeke AJP, Dekker JH, Van Eijk JT, Kostense PJ, Bezemer PD. Effect of lactic acid suppositories compared with oral metronidazole and placebo in bacterial vaginosis: a randomised clinical trial. Genitourin Med 1993;69:388-92.
11. Bro F. The diagnosis of candida vaginitis in general practice. Scand J Prim Health Care 1989;7:19-22.
12. Bro F, Juul S. Predictors of Chlamydia trachomatis infection in women in general practice. Fam Pract 1990a;7:138-43.
13. Bro F. Single-dose 500-mg clotrimazole vaginal tablets compared with placebo in the treatment of Candida vaginitis. J Fam Pract 1990b;31:148-52.
14. Brunham RC, Paavonen J, Stevens CE, Kiviat N, Kuo CC, Critchlow CW, et al. Mucopurulent cervicitis - the ignored counterpart in women of urethritis in men. N Engl J Med 1984;311: 1-6.
15. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995;172:525-9.
16. Caro-Paton T, Carvajal A, Martin de Diego I, Martin-Arias LH, Alvarez RA, Rodriguez PE. Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol 1997;44:179-82.
17. Commissie Farmaceutische Hulp. Farmacotherapeutisch Kompas: medisch farmaceutische voorlichting. Amstelveen: College voorZorgverzekeraars, 2004.
18. Czeizel AE, Rockenbauer M. A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol 1998;105:322-7.
19. Dekker JH, Boeke AJP, Van Eijk JTM. Vaginale klachten in de huisartspraktijk: waarom komen vrouwen en welke diagnosen worden bij hen gesteld? Huisarts Wet 1991;34:439-44.
20. Dekker JH, Boeke AJP, Den Hollander MHJ, Van Eijk JTM. Het onderzoek van de fluor bij vaginale klachten in de huisartspraktijk. Huisarts Wet 1992a;35:46-52.
21. Dekker JH, Boeke AJP. De voorspelling van de diagnose bij vaginale klachten. In: Dekker JH, Boeke AJP. Vaginale klachten in de huisartspraktijk [Proefschrift]. Amsterdam: Vrije Universiteit, 1992b.
22. Dekker JH, Boeke AJ, Janssens J, Van Eijk JT. Vaginal symptoms of unknown aetiology: a study in Dutch general practice. Br J Gen Pract 1993;43:239-44.
23. Ferris DG, Litaker MS, Woodward L, Mathis D, Hendrich J. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J Fam Pract 1995;41:443-9.
24. Fischbach F, Petersen EE, Weissenbacher ER, Martius J, Hosmann J, Mayer H. Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 1993;82:405-10.
25. Flynn CA, Helwig AL, Meurer LN. Bacterial vaginosis in pregnancy and the risk of prematurity: a meta-analysis. J Fam Pract 1999;48:885-92.
26. Fong IW. The value of prophylactic (monthly) clotrimazole versus empiric self-treatment in recurrent vaginal candidiasis. Genitourin Med 1994;70:124-6.
27. Goldsmid JM, Langley JM, Davies N. Trichomoniasis: some alternative views. Venerology 1991;3:96-8.
28. Hamrick M, Chambliss ML. Bacterial vaginosis and treatment of sexual partners. Arch Fam Med 2000;9:647-8.
29. Hillier SL, Krohn MA, Watts DH, Wolner-Hanssen P, Eschenbach D. Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis. Obstet Gynecol 1990;76:407-13.
30. Hillier SL, Lipinski C, Briselden AM, Eschenbach DA. Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis. Obstet Gynecol 1993;81:963-7.
31. Hillier SL, Holmes KK. Bacterial vaginosis. In: Holmes KK, Sparling PF, Mardh PA, editors. Sexually transmitted diseases. New York: McGraw-Hill, 1999.
32. Holmes KK, Stamm WE. Lower genital tract infection syndromes in women. In: Holmes KK, Sparling PF, Mardh PA, editors. Sexually transmitted diseases. New York: McGraw-Hill, 1999: 761-81.
33. Hook EW, Hunter Handsfield H. Gonococcal infections in the adult. In: Holmes KK, Sparling PF, Mardh PA, editors. Sexually transmitted diseases. New York: McGraw-Hill, 1999: 451-66.
34. Karasz A, Anderson M. The vaginitis monologues: women's experiences of vaginal complaints in a primary care setting. Soc Sci Med 2003;56:1013-21.
35. Kiss H, Petricevic L, Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ 2004;329:371.
36. Livengood CH III, Thomason JL, Hill GB. Bacterial vaginosis: treatment with topical intravaginal clindamycin phosphate. Obstet Gynecol 1990;76:118-23.
37. Livengood CH III, McGregor JA, Soper DE, Newton E, Thomason JL. Bacterial vaginosis: efficacy and safety of intravaginal metronidazole treatment. Am J Obstet Gynecol 1994;170:759-64.
38. Lugo-Miro VI, Green M, Mazur L. Comparison of different metronidazole therapeutic regimens for bacterial vaginosis. A meta-analysis. JAMA 1992;268:92-5.
39. MacNeill C, Carey JC. Recurrent vulvovaginal candidiasis. Curr Womens Health Rep 2001;1:31-5.
40. Mårdh PA, Taylor-Robinson D, editors. Bacterial vaginosis. Stockholm: Almqvist & Wiksell International, 1984.
41. Mårdh PA. Ascending chlamydial infections in the female genital tract. In: Oriel JD, Ridgway GL, Schachter J, Taylor-Robinson D, Ward ME, editors. Chlamydial infections. London: Cambridge UP, 1986.
42. Mårdh PA, Rodrigues AG, Genc M, Novikova N, Martinez-de-Oliveira J, Guaschino S. Facts and myths on recurrent vulvovaginal candidosis - a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy. Int J STD AIDS 2002;13:522-39.
43. McDonald H, Brocklehurst P, Parsons J, Vigneswaran R. Antibiotics for treating bacterial vaginosis in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 3, 2004. Chichester: John Wiley & Sons, 2004.
44. Meyboom RH, Havinga JS, Lastdrager CJ, De Koning GH. Beschadiging van condooms door vaginaal toegediende geneesmiddelen. Ned Tijdschr Geneeskd 1995;139:1602-5.
45. MMWR. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. Recommendations and reports (2000;51). http://www.cdc.gov/ mmwr/PDF/RR/RR5111.pdf 51, geraadpleegd februari 2005.
46. Nettleman MD, Jones RB. Cost-effectiveness of screening women at moderate risk for genital infections caused by Chlamydia trachomatis. JAMA 1988;260:207-13.
47. NVOG. Richtlijn Vulvodynie (2000). http://www. nvog.nl/files/ 31_vulvodynie.pfd, geraadpleegd november 2004.
48. NVOG. Richtlijn Preventie van perinatale groep-B-streptokokkenziekte (1998;12). http://www.nvog.nl/files/12_pre_peri_strep.pdf 12, geraadpleegd februari 2005.
49. Okkes IM, Oskam SK, Lamberts H. Van klacht naar diagnose: episodegegevens uit de huisartspraktijk. Bussum: Coutinho, 1998.
50. Reed BD, Huck W, Zazove P. Differentiation of Gardnerella vaginalis, Candida albicans, and Trichomonas vaginalis infections of the vagina. J Fam Pract 1989;28:673-80.
51. Rein MF. Trichomonas vaginalis. In: Mandell GL, Douglas RG, Bennett JE, editors. Principles and practice of infectious diseases. Philadelphia: Churchill Livingstone, 2000.
52. Schrag SI, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347(4):233-9.
53. Severijnen AJ. Chlamydia trachomatis als volksgezondheidsprobleem. Rotterdam: Instituut Maatschappelijke Gezondheidszorg, Erasmus Universiteit, 1992.
54. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1985;152:924-35.
55. Sobel JD, Schmitt C, Meriwether C. Clotrimazole treatment of recurrent and chronic candida vulvovaginitis. Obstet Gynecol 1989;73:330-4.
56. Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med 2004;351:876-83.
57. Spence D. Candidiasis (vulvovaginal). Clin Evid 2004;11:2344-57.
58. Taylor-Robinson D, Ainsworth JG, McCormack WM. Genital mycoplasms. In: Holmes KK, Sparling PF, Mardh PA, editors. Sexually transmitted diseases. New York: McGraw-Hill, 1999: 533-49.
59. Taylor-Robinson D, Morgan DJ, Sheehan M, Rosenstein IJ, Lamont RF. Relation between Gram-stain and clinical criteria for diagnosing bacterial vaginosis with special reference to Gram grade II evaluation. Int J STD AIDS 2003;14:6-10.
60. Van de Lisdonk EH, Van den Bosch WJHM, Lagro-Janssen ALM. Ziekten in de huisartspraktijk. 4e dr. Maarssen: Elsevier Gezondheidszorg, 2003.
61. Van den Hoek JA, Mulder-Folkerts DK, Coutinho RA, Dukers NH, Buimer M, Van Doornum GJ. Opportunistische screening op genitale infecties met Chlamydia trachomatis onder de seksueel actieve bevolking van Amsterdam. I: Meer dan 90% deelname en bijna 5% prevalentie. Ned Tijdschr Geneeskd 1999;143:668-72.
62. Van der Linden MW, Westert GP, De Bakker DH, Schellevis FG. Tweede nationale Studie naar ziekten en verrichtingen in de huisartspraktijk. Utrecht: NIVEL, 2004.
63. Van der Meijden WI, Bosch I, De Haes WFM, Lako CJ, Van Harten PW, Zorn H. Vaginale afscheiding: wat zeggen vrouwen er zelf over? Huisarts Wet 1985;28:387-91.
64. Van Royen P. Vaginal discharge and bacterial vaginosis in family practice [Proefschrift]. Antwerpen: Universiteit van Antwerpen, 1993.
65. Van Valkengoed IG, Boeke AJP, Van den Brule AJ, Morre SA, Dekker JH, Meijer CJ. Systematische opsporing van infecties met Chlamydia trachomatis bij mannen en vrouwen zonder klachten in de huisartsenpraktijk met behulp van per post verstuurde urinemonsters. Ned Tijdschr Geneeskd 1999;143:672-6.
66. Watson MC, Grimshaw JM, Bond CM, Mollison J, Ludbrook A. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush) (Cochrane Review). In: The Cochrane Library, Issue 3, 2004. Chichester: John Wiley & Sons, 2004.
67. Wiese W, Patel SR, Patel SC, Ohl CA, Estrada CA. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med 2000;108:301-8.
68. Young GL, Jewell D. Topical treatment for vaginal candidiasis (thrush) in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 3, 2004. Chichester: John Wiley & Sons, 2004.